Consular Services

In applying measures based on New Border Measures (28) (May 20, 2022), COVID-19 vaccination certificates recognized as valid since July 31, 2022, in principle, fall under any of the categories 1. or 2. below.

1. COVID-19 vaccination certificates issued in Japan which fall under any of the categories (1)-(3) below, and prove that at least three doses of COVID-19 vaccine are inoculated.
   • (1) COVID-19 vaccination certificates issued by either the Government of Japan or a local public authority/municipality in Japan (The COVID-19 Vaccination Certificate for overseas travel)
   • (2) Documents to prove vaccination for COVID-19 issued by a local public authority/municipality in Japan
   • (3) Records of Vaccination for COVID-19 issued by medical institutions in Japan
2. COVID-19 vaccination certificates issued abroad which fulfill all the three requirements (1)-(3) below.
   • (1) All relevant items described below should be listed on the certificate either in Japanese or English:
     Name, date of birth, product name or manufacturer of vaccines, vaccination date, number of COVID-19 vaccine doses (Note 1)
     • (Note 1) COVID-19 vaccination certificates written in languages other than Japanese or English are considered as valid if the translation (Japanese/English) is attached and all the items are clearly identifiable.
   • (2) The certificate should prove that at least two doses (As for JCOVDEN / Janssen, one dose is treated as two doses) of any of the COVID-19 vaccines described in the table a. below are inoculated, and any of the COVID-19 vaccines described in the table b. below is inoculated for the third vaccination or after. (Note 2)
     • a. COVID-19 vaccines up to the second dose:

       Product Name or Manufacturer

       COMIRNATY, Intramuscular injection / Pfizer

       Vaxzevria, Intramuscular injection / AstraZeneca (Note 3)

       Spikevax, Intramuscular injection / Moderna

       JCOVDEN / Janssen

       COVAXIN / Bharat Biotech

       Nuvaxovid, Intramuscular injection / Novavax (Note 3)

     • • (Note 2) Mix-and-match vaccines are also considered as valid.
       • (Note 3) In applying measures based on New Border Measures (28), COMIRNATY manufactured by Fosun Pharma / BioNTech and Covishield / COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection / Pfizer and Vaxzevria, Intramuscular injection / AstraZeneca, Nuvaxovid, Intramuscular injection / Novavax respectively.
     • b. COVID-19 vaccines for the third dose or after:

       Product Name or Manufacturer

       COMIRNATY, Intramuscular injection / Pfizer (Note 4)

       Spikevax, Intramuscular injection / Moderna

       Nuvaxovid, Intramuscular injection / Novavax (Note 4)

       Vaxzevria, Intramuscular injection / AstraZeneca (Note 4)

       JCOVDEN / Janssen

       COVAXIN / Bharat Biotech Note : To be recognized as valid after 0:00am(JST) July 31, 2022

     • • (Note 4) In applying measures based on New border measures (28), COMIRNATY manufactured by Fosun Pharma / BioNTech and Covishield / COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection / Pfizer and Vaxzevria, Intramuscular injection / AstraZeneca, Nuvaxovid, Intramuscular injection / Novavax respectively.
   • (3) The certificate should be issued by an official body, such as a government.